The publication of the genome sequence of Equus caballus in 2009 was driven by a need to identify the genetic contributions to equine diseases, coat, temperament, fertility & athletic performance. Performing reliable whole-genome expression profiling using Agilent Microarray is an important tool to develop tests for genetically complex equine diseases, novel treatments & improved genetic breeding programs.
Oligonucleotide quality, probe design and protocol flexibility allow us to obtain wide dynamic range, and unmatched sensitivity and reproducibility. Learn more about Agilents complete gene expression solution.
For Research Use Only. Not for use in diagnostic procedures.
Data generated by the Sequencing Quality Control
Consortium (SEQC) has shown that RNA-Seq and microarray-based gene expression
models are comparable in clinical endpoint prediction performance.